ILTREX

MediGene AG

Application Filed: 2002-05-15
Trademark Application Details
Trademark Logo ILTREX

Mark For: ILTREX™ trademark registration is intended to cover the categories of molecular biologically developed medicines, serums, therapeutic preparations for animals and humans for the treatment of cardiac diseases, skin diseases, cancer,diabetes and obesity; molecular biologically developed test kits for clinical and medical laboratory use, comprised of biochemical and biotechnological components for the identification, analysis and validation of target genes and/or the identification of new pharmaceutically active compounds for human medical and veterinary medical diagnostic and therapy purposes; and molecular biologically developed diagnostic preparations for clinical and medical laboratory use. [all]

Status

2022-07-23 UTC
DEAD UNKNOWN


Research OneLook Acronym Finder
Serial Number76410781
Mark Literal ElementsILTREX
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationFILE REPOSITORY (FRANCONIA) 2004-02-09
Basis44(e)
Class StatusABANDONED
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeBurns, Doane, Swecker & Mathis, L.L.P.
Attorney NameAdrienne L. White, Esquire
Attorney Docket Number032861-008
Law Office AssignedM60
Employee NameSMITH, BRIDGETT G

Timeline

2002-04-11Trademark Registered
2002-05-15Application Filed
2003-07-22Published
2003-07-22Published for Opposition
2003-12-05Abandon
2004-02-05Status: Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Tra
2004-02-05Status: Dead/Abandoned
2004-02-09Location: FILE REPOSITORY (FRANCONIA)
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: MediGene AG
AddressGesellschaft fur molekularbiologische Ka rdiologie und Onkologie Lochhamer Strasse 11 D-82152 Planegg/Martinsried GERMANY
Legal Entity TypeCorporation
Legal Entity StateGERMANY

Documents

Attorney of Record

ADRIENNE L. WHITE, ESQUIRE
BURNS, DOANE, SWECKER & MATHIS, L.L.P.
POST OFFICE BOX 1404
ALEXANDRIA, VIRGINIA 22313-1404

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: MOLECULAR BIOLOGICALLY DEVELOPED MEDICINES, SERUMS, THERAPEUT
IC PREPARATIONS FOR ANIMALS AND HUMANS FOR THE TREATMENT OF CARDIAC DISEASES, SKIN DISEASES, CANCER,DIABETES AND OBESITY; MOLECULAR BIOLOGICALLY DEVELOPED TEST KITS FOR CLINICAL AND MEDICAL LABORATORY USE, COMPRISED OF BIOCHEMICAL AND BIOTECHNOLOGICAL COMPONENTS FOR THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES AND/OR THE IDENTIFICATION OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMAN MEDICAL AND VETERINARY MEDICAL DIAGNOST
IC AND THERAPY PURPOSES; AND MOLECULAR BIOLOGICALLY DEVELOPED DIAGNOST
IC PREPARATIONS FOR CLINICAL AND MEDICAL LABORATORY USE

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051MOLECULAR BIOLOGICALLY DEVELOPED MEDICINES, SERUMS, THERAPEUTIC PREPARATIONS FOR ANIMALS AND HUMANS FOR THE TREATMENT OF CARDIAC DISEASES, SKIN DISEASES, CANCER,DIABETES AND OBESITY; MOLECULAR BIOLOGICALLY DEVELOPED TEST KITS FOR CLINICAL AND MEDICAL LABORATORY USE, COMPRISED OF BIOCHEMICAL AND BIOTECHNOLOGICAL COMPONENTS FOR THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES AND/OR THE IDENTIFICATION OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMAN MEDICAL AND VETERINARY MEDICAL DIAGNOSTIC AND THERAPY PURPOSES; AND MOLECULAR BIOLOGICALLY DEVELOPED DIAGNOSTIC PREPARATIONS FOR CLINICAL AND MEDICAL LABORATORY USE

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT - AFTER PUBLICATION2004-02-05
PAPER RECEIVED2003-12-05
EXTENSION OF TIME TO OPPOSE RECEIVED2003-09-03
FAX RECEIVED2003-08-04
PUBLISHED FOR OPPOSITION2003-07-22
NOTICE OF PUBLICATION2003-07-02
Sec. 1(B) CLAIM DELETED2003-05-2077075
APPROVED FOR PUB - PRINCIPAL REGISTER2003-04-30
PAPER RECEIVED2003-03-20
CORRESPONDENCE RECEIVED IN LAW OFFICE2003-03-20
ASSIGNED TO EXAMINER2002-10-0976582
NON-FINAL ACTION MAILED2002-09-20
ASSIGNED TO EXAMINER2002-09-0676684

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed